Get the Stockscreener App
67.68
0.89%
0.54
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $67.68, with a volume of 1.11M.
It is up +0.89% in the last 24 hours and up +2.46% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$67.14
Open:
$67.65
24h Volume:
1.11M
Relative Volume:
0.54
Market Cap:
$33.03B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
40.83
EPS:
1.6577
Net Cash Flow:
$1.59B
1W Performance:
-2.76%
1M Performance:
+2.46%
6M Performance:
-15.47%
1Y Performance:
-23.64%
1-Day Range:
$67.30
$68.05
1-Week Range:
$65.99
$69.00
52-Week Range:
$61.84
$92.55
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
67.72 | 32.74B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
406.32 | 145.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
152.15 | 41.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
40.96 | 34.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
205.32 | 30.24B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Alcon stock reflects steady growth prospects as eye care demand expands globally - AD HOC NEWS
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know - Zacks Investment Research
Alcon Inc focuses on eye care leadership as investors watch global demand - AD HOC NEWS
Alcon focus on eye care growth and global market presence - AD HOC NEWS
Alcon collaborates with RxSight to develop adjustable PCIOLs - MSN
Is Alcon (SWX:ALC) Cheap Following Its RxSight Collaboration And Premium P E? - simplywall.st
Is Alcon (SWX:ALC) Undervalued After Its RxSight Collaboration? - Yahoo Finance
Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones? - Insider Monkey
Alcon Inc focuses on eye care growth and global expansion - AD HOC NEWS
Systane Complete by Alcondry eye relief with lipid layer support - AD HOC NEWS
Alcon focuses on eye-care growth as global demand for vision treatments expands - Ad-hoc-news.de
RxSight: Alcon Deal Reshapes The Long-Term Growth Story (NASDAQ:RXST) - Seeking Alpha
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs - InvisionMag.com
Alcon and RxSight partner to to develop light-adjustable PCIOLs - Eyes On Eyecare
Alcon focuses on global eye care growth as a diversified medical device leader - AD HOC NEWS
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada - AOL.com
RXST: Collaboration with Alcon and product innovation offset Q2 headwinds, supporting revised 2026 outlook - TradingView
Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs - Medical Product Outsourcing
DAILIES TOTAL1 from Alcon Inc.daily lenses engineered for all?day comfort - AD HOC NEWS
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal - Investing.com
Stifel reiterates Hold on RxSight stock, $8 target on Alcon deal By Investing.com - Investing.com Nigeria
Alcon focuses on eye care growth as a global leader - AD HOC NEWS
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight - Yahoo Finance
Alcon focuses on eye care growth as demand for vision treatments rises - AD HOC NEWS
Alcon focuses on eye care growth as investors watch long-term trends - AD HOC NEWS
Alcon, RxSight Partner to Develop Adjustable Presbyopia-Correcting IOLs - VisionMonday.com
Alcon Silver Announces Shareholder Approval of Arrangement - Yahoo Finance
Alcon, RxSight partner on adjustable lens technology - Investing.com UK
Alcon, RxSight partner on adjustable lens technology By Investing.com - Investing.com South Africa
Alcon (ALC) Partners with RxSight for Innovative Lens Developmen - GuruFocus
ALCON AGRXSIGHT TO RECEIVE $60 MLN UPFRONT PAYMENT UNDER AGREEMENT - Moomoo
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement - The Manila Times
Alcon and RxSight team up to develop light-adjustable cataract lenses - StreetInsider
Alcon–RxSight (NASDAQ: RXST) deal adds $60M upfront plus milestones, royalties - Stock Titan
Alcon and RxSight team up on adjustable lenses after cataract surgery - Stock Titan
Alcon focuses on eye care growth as investors watch long-term strategy - AD HOC NEWS
Price to sales forward of Alcon AG – SIX:ALC - TradingView
Alcon stock tracks its core eye care business. Investors await fresh cues. - Ad-hoc-news.de
Alcon Inc. (ALC) Stock Analysis: Eyeing A 26% Upside With Solid Buy Ratings - DirectorsTalk Interviews
Alcon focuses on ophthalmic growth as investor interest builds - AD HOC NEWS
Alcon stock holds its footing. Focus turns to the eye-care model. - AD HOC NEWS
Harding Loevner International Equity Portfolio's Alcon Inc(ALC) Holding History - GuruFocus
Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100 - GuruFocus
SYSTANE Ultra from Alcon Inc.Dry eye relief built for digital days - AD HOC NEWS
Alcon Inc focuses on eye-care growth as global demand for vision treatment expands - AD HOC NEWS
List of 19 Acquisitions by Alcon (Jul 2026) - Tracxn
DAILIES TOTAL1 contact lenses from Alcon Inc.daily disposables built for long screen days - AD HOC NEWS
Enterprise value to revenue forward of Alcon AG – VIE:ALC - TradingView
Total30 contact lenses from Alcon Inc.monthly comfort with water gradient tech - AD HOC NEWS
ALCAlcon Inc Latest SEC Filings - Finviz
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):